Tesamorelin 10 mg is a multi-dose vial configuration of a synthetic growth hormone-releasing hormone (GHRH) analogue, primarily prescribed under brand names like Egrifta to reduce excess deep belly (visceral) fat in adults with HIV-associated lipodystrophy. It functions by prompting the pituitary gland to produce natural growth hormone. [1, 2, 3]
Overview and Function
- Mechanism: Acts as a GHRH analog to stimulate endogenous growth hormone and increase IGF-1, targeting visceral adipose tissue.
- Approval Status: FDA-approved specifically for HIV-associated lipodystrophy; other uses remain investigational or off-label.
Common Considerations & Safety
- Medical Supervision: Clinical management requires regular monitoring of IGF-1 levels and blood glucose parameters by a healthcare provider. [1]
If you are evaluating this medication, please let me know:
-
What specific condition or goal you are addressing
-
Whether you have a current prescription or physician guidance
I can provide more targeted safety data or contextual details.
What does taking tesamorelin do?
Tesamorelin is a synthetic peptide and growth hormone-releasing hormone (GHRH) analog. It stimulates the pituitary gland to produce and release natural pulses of growth hormone, which specifically targets and reduces deep visceral belly fat surrounding internal organs without causing generalized weight loss.
Rite Aid +3
Main Medical Use
- HIV-associated lipodystrophy: It is officially approved by the FDA (under brand names like ) to reduce excess stomach fat in adults with HIV.
- Fat breakdown:
Signals fat cells to break down deep visceral adipose tissue.
- Muscle preservation: Helps maintain or support lean muscle mass and protein synthesis.
- Metabolic markers: Can improve lipid profiles, such as lowering triglycerides.
Rite Aid +3
- Joint stiffness or muscle aches
- Injection-site redness, itching, or pain
- Swelling or fluid retention
- Changes in blood sugar levels or glucose tolerance
Mayo Clinic +3






Avis
Il n’y a pas encore d’avis.